Stay updated on Efficacy of Losmapimod in FSHD Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Losmapimod in FSHD Clinical Trial page.

Latest updates to the Efficacy of Losmapimod in FSHD Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.7%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has undergone significant revisions regarding the study of Losmapimod for Facioscapulohumeral Muscular Dystrophy (FSHD), including updates to the study design and investigator details.SummaryDifference17%
Stay in the know with updates to Efficacy of Losmapimod in FSHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Losmapimod in FSHD Clinical Trial page.